TrialCurrent pharmaceutical design2025

The Efficacy of Oral Atorvastatin for Skin Toxicity in Breast Cancer Patients Undergoing Radiotherapy: A Randomized, Double-blind, Placebo-controlled Trial.

Mahmonir Danesh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.